first-line pharmacotherapy for obesity

first-line pharmacotherapy for obesity

3 Secrets Your Doctor Won’t Say About Your Semaglutide Prescription

Semaglutide and tirzepatide are now classified as first-line pharmacotherapy for obesity, meaning doctors can prescribe them at the initial visit for qualifying patients. In 2024 the American College of Physicians (ACP) upgraded these GLP-1 agonists to the top tier of a four-step algorithm, removing the old “six-month diet-only” prerequisite and